95 related articles for article (PubMed ID: 22445882)
41. Real-time voltammetric detection of cocaine-induced dopamine changes in the striatum of freely moving mice.
Oleson EB; Salek J; Bonin KD; Jones SR; Budygin EA
Neurosci Lett; 2009 Dec; 467(2):144-6. PubMed ID: 19822192
[TBL] [Abstract][Full Text] [Related]
42. Behavioral and neurochemical effects of cocaine and diphenhydramine combinations in rhesus monkeys.
Banks ML; Andersen ML; Murnane KS; Meyer RC; Howell LL
Psychopharmacology (Berl); 2009 Aug; 205(3):467-74. PubMed ID: 19430765
[TBL] [Abstract][Full Text] [Related]
43. Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors.
Hiranita T; Soto PL; Newman AH; Katz JL
J Pharmacol Exp Ther; 2009 May; 329(2):677-86. PubMed ID: 19228996
[TBL] [Abstract][Full Text] [Related]
44. Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.
Mooney ME; Herin DV; Schmitz JM; Moukaddam N; Green CE; Grabowski J
Drug Alcohol Depend; 2009 Apr; 101(1-2):34-41. PubMed ID: 19058926
[TBL] [Abstract][Full Text] [Related]
45. Super-additive interaction of the reinforcing effects of cocaine and H1-antihistamines in rhesus monkeys.
Wang Z; Woolverton WL
Pharmacol Biochem Behav; 2009 Feb; 91(4):590-5. PubMed ID: 18930758
[TBL] [Abstract][Full Text] [Related]
46. The principles of agonist pharmacotherapy for psychostimulant dependence.
Shearer J
Drug Alcohol Rev; 2008 May; 27(3):301-8. PubMed ID: 18368612
[TBL] [Abstract][Full Text] [Related]
47. Cocaine-like neurochemical effects of antihistaminic medications.
Tanda G; Kopajtic TA; Katz JL
J Neurochem; 2008 Jul; 106(1):147-57. PubMed ID: 18363822
[TBL] [Abstract][Full Text] [Related]
48. DrugBank: a knowledgebase for drugs, drug actions and drug targets.
Wishart DS; Knox C; Guo AC; Cheng D; Shrivastava S; Tzur D; Gautam B; Hassanali M
Nucleic Acids Res; 2008 Jan; 36(Database issue):D901-6. PubMed ID: 18048412
[TBL] [Abstract][Full Text] [Related]
49. Simultaneous determination of ten antihistamine drugs in human plasma using pipette tip solid-phase extraction and gas chromatography/mass spectrometry.
Hasegawa C; Kumazawa T; Lee XP; Fujishiro M; Kuriki A; Marumo A; Seno H; Sato K
Rapid Commun Mass Spectrom; 2006; 20(4):537-43. PubMed ID: 16419026
[TBL] [Abstract][Full Text] [Related]
50. The synthesis and biological evaluation of dopamine transporter inhibiting activity of substituted diphenylmethoxypiperidines.
Lapa GB; Byrd GD; Lapa AA; Budygin EA; Childers SR; Jones SR; Harp JJ
Bioorg Med Chem Lett; 2005 Nov; 15(22):4915-8. PubMed ID: 16165350
[TBL] [Abstract][Full Text] [Related]
51. Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties.
Lapa GB; Mathews TA; Harp J; Budygin EA; Jones SR
Eur J Pharmacol; 2005 Jan; 506(3):237-40. PubMed ID: 15627433
[TBL] [Abstract][Full Text] [Related]
52. Advances in H1-antihistamines.
Simons FE
N Engl J Med; 2004 Nov; 351(21):2203-17. PubMed ID: 15548781
[No Abstract] [Full Text] [Related]
53. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.
Grabowski J; Shearer J; Merrill J; Negus SS
Addict Behav; 2004 Sep; 29(7):1439-64. PubMed ID: 15345275
[TBL] [Abstract][Full Text] [Related]
54. Parsing reward.
Berridge KC; Robinson TE
Trends Neurosci; 2003 Sep; 26(9):507-13. PubMed ID: 12948663
[TBL] [Abstract][Full Text] [Related]
55. Chloral hydrate and ethanol, but not urethane, alter the clearance of exogenous dopamine recorded by chronoamperometry in striatum of unrestrained rats.
Sabeti J; Gerhardt GA; Zahniser NR
Neurosci Lett; 2003 May; 343(1):9-12. PubMed ID: 12749985
[TBL] [Abstract][Full Text] [Related]
56. A role for presynaptic mechanisms in the actions of nomifensine and haloperidol.
Garris PA; Budygin EA; Phillips PE; Venton BJ; Robinson DL; Bergstrom BP; Rebec GV; Wightman RM
Neuroscience; 2003; 118(3):819-29. PubMed ID: 12710989
[TBL] [Abstract][Full Text] [Related]
57. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development.
Platt DM; Rowlett JK; Spealman RD
Psychopharmacology (Berl); 2002 Oct; 163(3-4):265-82. PubMed ID: 12373428
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms and abuse liability of the anti-histamine dimenhydrinate.
Halpert AG; Olmstead MC; Beninger RJ
Neurosci Biobehav Rev; 2002 Jan; 26(1):61-7. PubMed ID: 11835984
[TBL] [Abstract][Full Text] [Related]
59. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry.
Wu Q; Reith ME; Wightman RM; Kawagoe KT; Garris PA
J Neurosci Methods; 2001 Dec; 112(2):119-33. PubMed ID: 11716947
[TBL] [Abstract][Full Text] [Related]
60. Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients.
Ohno T; Kobayashi S; Hayashi M; Sakurai M; Kanazawa I
J Neurol Sci; 2001 Jan; 182(2):95-7. PubMed ID: 11137513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
